(1) Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;(2) Department of Molecular Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;
Abstract:
Background
BRCA1 and BRCA2 are two major tumor suppressor genes for hereditary breast and ovarian cancer. In sporadic breast cancer, although somatic mutations of these genes are rare, loss of heterozygosity (LOH) at BRCA1 and BRCA2 loci is common.